Regulatory Alliances


ASGCT is involved in collaborative activities to provide expert input into regulatory and commercialization issues surrounding gene and cell therapy. These collaborations are designed to overcome significant challenges and promote certain values, such as quality, safety and standardization. ASGCT members provide expertise as representatives in the following groups on an ongoing basis:

Alliance for Regenerative Medicine Gene and Gene Therapy Technology Section

Foundation for Accreditation of Cellular Therapy (FACT) Professional Relations Committee

National Academies of Sciences, Engineering and Medicine Forum on Regenerative Medicine

Standards Coordinating Body – Gene Therapy Sector and Cell Therapy Sector

Legislative Coalitions

Through coalitions, ASGCT advocates for federal research funding and educates policy makers about gene and cell therapy

Recent Collaborative Government Affairs Actions

Learn about ASGCT's most recent legislative actions and join our collaborative efforts. 

2019
22nd Annual Meeting
April 29 – May 2 | Washington D.C.
Close